Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec:141:106902.
doi: 10.1016/j.vph.2021.106902. Epub 2021 Aug 5.

Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients

Heather J LaClair  1 , Nadia Khosrodad  2 , Anupam A Sule  3 , Tracy Koehler  4 , Geetha Krishnamoorthy  5
Affiliations
Comment

Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients

Heather J LaClair et al. Vascul Pharmacol. 2021 Dec.
No abstract available

Keywords: Angiotensin receptor antagonists; Angiotensin-converting enzyme inhibitors; COVID-19; Hospital mortality; Length of stay.

PubMed Disclaimer

Comment on

References

    1. Wrapp D., Wang N., Corbett K.S., et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi: 10.1126/science.abb2507. - DOI - PMC - PubMed
    1. Griendling K.K., Sorescu D., Lasse B., Ushio-fukai M. Modulation of protein kinase activity and gene expression physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 2000:2175–2183. - PubMed
    1. Fosbøl E.L., Butt J.H., Østergaard L., et al. Association of Angiotensin-Converting Enzyme Inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. JAMA - J Am Med Assoc. 2020:1–10. doi: 10.1001/jama.2020.11301. - DOI - PMC - PubMed

Substances